Humans, Mice, and Mechanisms of Intestinal Atresias: A Window into Understanding Early Intestinal Development

Journal of Gastrointestinal Surgery

Volumn 15, Issue 4, 2011, Pages 694-700

  Nichol, Peter F ^a   Reeder, Amy ^a   Botham, Robert ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Duodenum; Epithelial plug; Hypothesis; Intestinal atresia; Intestinal development; Intestinal growth; Mechanism; Vascular hypothesis

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN;

ANIMAL; ARTICLE; DISEASE MODEL; GENE FREQUENCY; GENETICS; HUMAN; INTESTINE ATRESIA; MOUSE; PRENATAL DEVELOPMENT;

ANIMALS; DISEASE MODELS, ANIMAL; FACTOR V; GENE FREQUENCY; HUMANS; INTESTINAL ATRESIA; MICE;

EID: 79953110189     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-010-1400-y     Document Type: Article

References (67)

1. International Clearinghouse for Birth Defects Surveillance and Research. Annual report 2007.
2. Duodenal atresia and stenosis. In O'Neill JA Jr RM, Grosfeld JL, et al eds. Pediatric Surgery, Vol. 2. St Louis, Mo: Mosby, 1998.
3. Tandler J. Zur Entwicklungsgeschichte des menschlichen Duodenum in fruhen Embryonalstadien. Morphol Jahrb 1900; 29: 187.
4. Cheng W, Tam PK. Murine duodenum does not go through a "solid core" stage in its embryological development. Eur J Pediatr Surg 1998; 8(4): 212-5.
5. Fairbanks TJ, Kanard R, Del Moral PM, et al. Fibroblast growth factor receptor 2 IIIb invalidation--a potential cause of familial duodenal atresia. J Pediatr Surg 2004; 39(6): 872-4.
6. Kanard RC, Fairbanks TJ, De Langhe SP, et al. Fibroblast growth factor-10 serves a regulatory role in duodenal development. J Pediatr Surg 2005; 40(2): 313-6.
7. Louw JH, Barnard CN. Congenital intestinal atresia; observations on its origin. Lancet 1955; 269(6899): 1065-7.
8. Barnard CN. The genesis of intestinal atresia. Surg Forum 1957; 7: 393-6.
9. Barnard CN, Louw JH. The genesis of intestinal atresia. Minn Med 1956; 39(11): 745; passim.
10. Abdullah F, Arnold MA, Nabaweesi R, et al. Gastroschisis in the United States 1988-2003: analysis and risk categorization of 4344 patients. J Perinatol 2007; 27(1): 50-5.
11. Stollman TH, Wijnen RM, Draaisma JM. Investigation for cystic fibrosis in infants with jejunoileal atresia in the Netherlands: a 35-year experience with 114 cases. Eur J Pediatr 2007; 166(9): 989-90.
12. Roberts HE, Cragan JD, Cono J, et al. Increased frequency of cystic fibrosis among infants with jejunoileal atresia. Am J Med Genet 1998; 78(5): 446-9.
13. Dalla Vecchia LK, Grosfeld JL, West KW, et al. Intestinal atresia and stenosis: a 25-year experience with 277 cases. Arch Surg 1998; 133(5): 490-6; discussion 496-7.
14. Johnson SM, Meyers RL. Inherited thrombophilia: a possible cause of in utero vascular thrombosis in children with intestinal atresia. J Pediatr Surg 2001; 36(8): 1146-9.
15. Greer FR (2010) Vitamin K the basics-What's new? Early Hum Dev. 86: 43-47.
16. Bowen DJ, Bowley S, John M, Collins PW. Factor V Leiden (G1691A), the prothrombin 3′-untranslated region variant (G20210A) and thermolabile methylenetetrahydrofolate reductase (C677T): a single genetic test genotypes all three loci--determination of frequencies in the S. Wales population of the UK. Thromb Haemost 1998; 79(5): 949-54.
17. Arruda VR, Annichino-Bizzacchi JM, Costa FF, Reitsma PH. Factor V Leiden (FVQ 506) is common in a Brazilian population. Am J Hematol 1995; 49(3): 242-3.
18. Asindi AA, Al-Daama SA, Zayed MS, Fatinni YA. Congenital malformation of the gastrointestinal tract in Aseer region, Saudi Arabia. Saudi Med J 2002; 23(9): 1078-82.
19. Frances F, Portoles O, Gabriel F, et al. [Factor V Leiden (G1691A) and prothrombin-G20210A alleles among patients with deep venous thrombosis and in the general population from Spain]. Rev Med Chil 2006; 134(1): 13-20.
20. Garcia-Gala JM, Alvarez V, Pinto CR, et al. Factor V Leiden (R506Q) and risk of venous thromboembolism: a case-control study based on the Spanish population. Clin Genet 1997; 52(4): 206-10.
21. Gibson CS, MacLennan AH, Rudzki Z, et al. The prevalence of inherited thrombophilias in a Caucasian Australian population. Pathology 2005; 37(2): 160-3.
22. Hepner M, Roldan A, Pieroni G, et al. Factor V Leiden mutation in the Argentinian population. Thromb Haemost 1999; 81(6): 989.
23. Herrmann FH, Koesling M, Schroder W, et al. Prevalence of factor V Leiden mutation in various populations. Genet Epidemiol 1997; 14(4): 403-11.
24. Hudecek J, Dobrotova M, Hybenova J, et al. [Factor V Leiden and the Slovak population]. Vnitr Lek 2003; 49(11): 845-50.
25. McCowan LM, Craigie S, Taylor RS, et al. Inherited thrombophilias are not increased in "idiopathic" small-for-gestational-age pregnancies. Am J Obstet Gynecol 2003; 188(4): 981-5.
26. Nurk E, Tell GS, Refsum H, et al. Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study. QJM 2006; 99(5): 289-98.
27. Palomo I, Pereira J, Alarcon M, et al. [Factor V Leiden and prothrombin G20210A among Chilean patients with venous and arterial thrombosis]. Rev Med Chil 2005; 133(12): 1425-33.
28. Pecheniuk NM, Marsh NA, Walsh TP. Multiple analysis of three common genetic alterations associated with thrombophilia. Blood Coagul Fibrinolysis 2000; 11(2): 183-9.
29. Zoller B, Norlund L, Leksell H, et al. High prevalence of the FVR506Q mutation causing APC resistance in a region of southern Sweden with a high incidence of venous thrombosis. Thromb Res 1996; 83(6): 475-7.
30. Balogh I, Poka R, Pfliegler G, et al. High prevalence of factor V Leiden mutation and 20210A prothrombin variant in Hungary. Thromb Haemost 1999; 81(4): 660-1.
31. Clark P, Walker ID, Govan L, et al. The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes. Br J Haematol 2008; 140(2): 236-40.
32. Dizon-Townson DS, Meline L, Nelson LM, et al. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol 1997; 177(2): 402-5.
33. Jaaskelainen E, Toivonen S, Romppanen EL, et al. M385T polymorphism in the factor V gene, but not Leiden mutation, is associated with placental abruption in Finnish women. Placenta 2004; 25(8-9): 730-4.
34. Kobashi G, Kato EH, Morikawa M, et al. MTHFR C677T Polymorphism and factor V Leiden mutation are not associated with recurrent spontaneous abortion of unexplained etiology in Japanese women. Semin Thromb Hemost 2005; 31(3): 266-71.
35. Lee DH, Henderson PA, Blajchman MA. Prevalence of factor V Leiden in a Canadian blood donor population. CMAJ 1996; 155(3): 285-9.
36. Prochazka M, Lubusky M, Slavik L, et al. Frequency of selected thrombophilias in women with placental abruption. Aust N Z J Obstet Gynaecol 2007; 47(4): 297-301.
37. Saour JN, Shoukri MM, Mammo LA. The Saudi Thrombosis and Familial Thrombophilia Registry. Design, rational, and preliminary results. Saudi Med J 2009; 30(10): 1286-90.
38. Sottilotta G, Mammi C, Furlo G, et al. High incidence of factor V Leiden and prothrombin G20210A in healthy southern Italians. Clin Appl Thromb Hemost 2009; 15(3): 356-9.
39. Vaughan J, Power C, Nolan C, et al. The incidence of factor V Leiden in a normal Irish population and its relationship to the laboratory diagnosis of APC resistance. Thromb Haemost 1999; 81(4): 661-3.
40. Batalla A, Alvarez R, Reguero JR, et al. Synergistic effect between apolipoprotein E and angiotensinogen gene polymorphisms in the risk for early myocardial infarction. Clin Chem 2000; 46(12): 1910-5.
41. Berthier MT, Houde A, Bergeron J, et al. Effect of the factor VII R353Q missense mutation on plasma apolipoprotein B levels: impact of visceral obesity. J Hum Genet 2003; 48(7): 367-73.
42. Bowman R, Joosen AM, Welch AA, et al. Factor VII, blood lipids and fat intake: gene-nutrient interaction and risk of coronary heart disease with the factor VII R353Q polymorphism. Eur J Clin Nutr 2009; 63(6): 771-7.
43. Di Castelnuovo A, D'Orazio A, Amore C, et al. Genetic modulation of coagulation factor VII plasma levels: contribution of different polymorphisms and gender-related effects. Thromb Haemost 1998; 80(4): 592-7.
44. Eriksson-Berg M, Deguchi H, Hawe E, et al. Influence of factor VII gene polymorphisms and environmental factors on plasma coagulation factor VII concentrations in middle-aged women with and without manifest coronary heart disease. Thromb Haemost 2005; 93(2): 351-8.
45. Lindman AS, Pedersen JI, Arnesen H, et al. Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease. Thromb Res 2004; 113(1): 57-65.
46. Kakko S, Elo T, Tapanainen JM, et al. Polymorphisms of genes affecting thrombosis and risk of myocardial infarction. Eur J Clin Invest 2002; 32(9): 643-8.
47. Doggen CJ, Manger Cats V, Bertina RM, et al. A genetic propensity to high factor VII is not associated with the risk of myocardial infarction in men. Thromb Haemost 1998; 80(2): 281-5.
48. Heywood DM, Carter AM, Catto AJ, et al. Polymorphisms of the factor VII gene and circulating FVII: C levels in relation to acute cerebrovascular disease and poststroke mortality. Stroke 1997; 28(4): 816-21.
49. Mrozikiewicz PM, Cascorbi I, Ziemer S, et al. Reduced procedural risk for coronary catheter interventions in carriers of the coagulation factor VII-Gln353 gene. J Am Coll Cardiol 2000; 36(5): 1520-5.
50. Nishiuma S, Kario K, Nakanishi K, et al. Factor VII R353Q polymorphism and lacunar stroke in Japanese hypertensive patients and normotensive controls. Blood Coagul Fibrinolysis 1997; 8(8): 525-30.
51. Perveen R, Lloyd IC, Clayton-Smith J, et al. Phenotypic variability and asymmetry of Rieger syndrome associated with PITX2 mutations. Invest Ophthalmol Vis Sci 2000; 41(9): 2456-60.
52. Eggenschwiler J, Ludwig T, Fisher P, et al. Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. Genes Dev 1997; 11(23): 3128-42.
53. Rice R, Spencer-Dene B, Connor EC, et al. Disruption of Fgf10/Fgfr2b-coordinated epithelial-mesenchymal interactions causes cleft palate. J Clin Invest 2004; 113(12): 1692-700.
54. Riley BM, Mansilla MA, Ma J, et al. Impaired FGF signaling contributes to cleft lip and palate. Proc Natl Acad Sci U S A 2007; 104(11): 4512-7.
55. Riley BM, Schultz RE, Cooper ME, et al. A genome-wide linkage scan for cleft lip and cleft palate identifies a novel locus on 8p11-23. Am J Med Genet A 2007; 143A(8): 846-52.
56. Conrad C, Freitas A, Clifton MS, Durham MM Hereditary multiple intestinal atresias: 2 new cases and review of the literature. J Pediatr Surg 2010; 45(4): E21-4.
57. Pameijer CR, Hubbard AM, Coleman B, Flake AW. Combined pure esophageal atresia, duodenal atresia, biliary atresia, and pancreatic ductal atresia: prenatal diagnostic features and review of the literature. J Pediatr Surg 2000; 35(5): 745-7.
58. Nijmeijer RM, Leeuwis JW, DeLisio A, et al. Visceral endoderm induces specification of cardiomyocytes in mice. Stem Cell Res 2009; 3(2-3): 170-8.
59. Fairbanks TJ, Kanard RC, De Langhe SP, et al. A genetic mechanism for cecal atresia: the role of the Fgf10 signaling pathway. J Surg Res 2004; 120(2): 201-9.
60. Fairbanks TJ, Kanard RC, Del Moral PM, et al. Colonic atresia without mesenteric vascular occlusion. The role of the fibroblast growth factor 10 signaling pathway. J Pediatr Surg 2005; 40(2): 390-6.
61. Fairbanks TJ, Sala FG, Kanard R, et al. The fibroblast growth factor pathway serves a regulatory role in proliferation and apoptosis in the pathogenesis of intestinal atresia. J Pediatr Surg 2006; 41(1): 132-6; discussion 132-6.
62. Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol 2001; 2(3): 3005: 1-9.
63. Ramalho-Santos M, Melton DA, McMahon AP. Hedgehog signals regulate multiple aspects of gastrointestinal development. Development 2000; 127(12): 2763-72.
64. Gao N, White P, Kaestner KH. Establishment of intestinal identity and epithelial-mesenchymal signaling by Cdx2. Dev Cell 2009; 16(4): 588-99.
65. Martinovic-Bouriel J, Bernabe-Dupont C, Golzio C, et al. Matthew-Wood syndrome: report of two new cases supporting autosomal recessive inheritance and exclusion of FGF10 and FGFR2. Am J Med Genet A 2007; 143(3): 219-28.
66. Mo R, Kim JH, Zhang J, et al. Anorectal malformations caused by defects in sonic hedgehog signaling. Am J Pathol 2001; 159(2): 765-74.
67. FitzSimmons J, Chinn A, Shepard TH. Normal length of the human fetal gastrointestinal tract. Pediatr Pathol 1988; 8(6): 633-41.